Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacteremia | Preclinical | China | 21 Jun 2023 | |
Conjunctivitis, Allergic | Preclinical | China | 21 Jun 2023 | |
Diabetes Mellitus | Preclinical | China | 21 Jun 2023 | |
Lung Diseases, Obstructive | Preclinical | China | 21 Jun 2023 | |
Nephritis | Preclinical | China | 21 Jun 2023 | |
Rheumatoid Arthritis | Preclinical | China | 21 Jun 2023 | |
Rhinitis, Allergic | Preclinical | China | 21 Jun 2023 |